Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
A study for children with sickle cell using study drug Hydroxyurea
Sponsor: National Institutes of Health
Enrolling: Male and Female Patients
Study Length: 6 Months
IRB Number: AAAJ7350
U.S. Govt. ID: NCT02029742
Contact: Nancy Green: 212-305-0494 / nsg11@columbia.edu
Additional Study Information: The purpose of this research is to learn how to help parent youth pairs work together to help youth with sickle cell disease take hydroxyurea every day as a daily habit. This study is for children and teens ages 10-18 with Sickle Cell Anemia taking hydroxyurea, and their parents (or guardians). Many children and teens do not use hydroxyurea every day. Daily use of hydroxyurea can help it work better to improve health. Taking it every day would be a healthy habit. This study, will evaluate whether those methods are useful for learning to take hydroxyurea every day.
This study is closed
Nancy Green, MD
Do You Qualify?
Is your child currently prescribed hydroxyurea? Yes No
Is your child able to speak/read English or Spanish? Yes No
Does your child have Sickle type - homozygous sickle disease or sickle-beta thalassemia disease? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Nancy Green